TAVI and the left ventricular myocardium

Facilitators: P. Pibarot, P. Genereux

Speakers: J. Steffen, I. Loewenstein, L. Tao, L. Tartuce, G. Versteeg

Summary

Understand the intricate relationship between TAVI and left ventricular myocardium through discussions on cardiac damage stages, functional remodeling, and pharmacological interventions post-TAVR. This session also reviews prophylactic ECMO support in high-risk patients, offering a comprehensive perspective on optimizing TAVI outcomes.

Presentations available when logged in:

Stages of cardiac damage in aortic stenosis patients undergoing TAVR
Failure to Wait for Transcatheter Aortic Valve implantation: Correlation with Cardiac Damage Stage
Impact of TAVR on cardiac function and left ventricular remodeling in pure aortic regurgitation
Renin-angiotensin system inhibitors following TAVR: an updated meta-analysis of 34,987 patients
Prophylactic ECMO support in high-risk TAVI in patients with severe left ventricular dysfunction

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

TAVI and the left ventricular myocardium

Log in or create account for free